None of that is a moral failure
The key question will be durability: long-term tolerability, adherence, safety, cost, and whether these outcomes can be maintained outside highly selected trial populations
While semaglutide focuses on one pathway, tirzepatide is a dual-action agonist , meaning it activates two different hormone receptors, not just one
Peptide therapy is a fantastic option for many, but it isnt the right fit for everyone
If used in performance animals, the regulations of the relevant authorities regarding medication should be observed
And, when you combine Setria with LivOn's liposomal encapsulation process, you get a very potent supplement that will be properly absorbed so it can do what it says it will, and without destroying your gut (like some supplements do)